VEGFR2/CD309 Antikörper

Produktnummer ABIN7648076

Der Maus Monoklonal Anti-VEGFR2/CD309-Antikörper wurde für WB, IHC, IP und ICC validiert. Er ist geeignet, VEGFR2/CD309 in Proben von Human zu detektieren.

Kurzübersicht für VEGFR2/CD309 Antikörper (ABIN7648076)

Target: VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser VEGFR2/CD309 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)

Klon: C10

Produktdetails anti-VEGFR2/CD309 Antikörper

Verwendungszweck: Monoclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)

Spezifität: The antibody is a mouse monoclonal antibody raised against VEGFR2. It has been selected for its ability to recognize VEGFR2 in immunohistochemical staining and western blotting.

Aufreinigung: Protein A + Protein G affinity chromatography

Immunogen: EPB367Hu61Eukaryotic Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)

Anwendungsinformationen

Applikationshinweise: Western blotting: 0.5-2 μg/mL,Immunohistochemistry: 5-20 μg/mL,Immunocytochemistry: 5-20 μg/mL,Optimal working dilutions must be determined by end user.

Kommentare:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Details zu VEGFR2/CD309

Target: VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Andere Bezeichnung: VEGFR2

Hintergrund: CD309, FLK1, VEGFR, KDR, A Type III Receptor Tyrosine Kinase, Kinase Insert Domain Receptor, Kinase Insert Domain Receptor, Fetal Liver Kinase-1

UniProt: P35968

Pathways: RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling